Skip to Main Content

Paper Details

Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center Analysis.
Cancers (Basel)
18
2021
Cancer, MTB, Tumor, cancer, oncologic malignancies, patient, patients
Author NameAffiliation
Martin BoekerComprehensive Cancer Center Freiburg, Medical Center, University of Freiburg
Martin BoekerInstitute for Medical Biometry and Statistics, Medical Center, University of Freiburg
Martin BoekerComprehensive Cancer Center Freiburg, Medical Center, University of Freiburg
Martin BoekerInstitute for Medical Biometry and Statistics, Medical Center, University of Freiburg
Simone HettmerComprehensive Cancer Center Freiburg, Medical Center, University of Freiburg
Simone HettmerMedical Center, University of Freiburg
Simone HettmerComprehensive Cancer Center Freiburg, Medical Center, University of Freiburg
Simone HettmerMedical Center, University of Freiburg
Nikolas von BubnoffMedical Center, University of Freiburg
Nikolas von BubnoffComprehensive Cancer Center Freiburg, Medical Center, University of Freiburg
Nikolas von BubnoffPartner Site Freiburg and German Cancer Research Center (DKFZ)
  • 1 - 11

Datasets

Release 1.2